{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:48:43Z","timestamp":1774460923645,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00347-024-02025-5","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T09:02:10Z","timestamp":1712566930000},"page":"333-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ophthalmika in der Schwangerschaft","Ophthalmic agents during pregnancy"],"prefix":"10.1007","volume":"121","author":[{"given":"Torsten","family":"Schlote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Germann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"publisher","unstructured":"(2021) European glaucoma society terminology and guidelines for glaucoma, 5th\u00a0edition. Br J Ophthalmol 105:1\u2013169. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines","DOI":"10.1136\/bjophthalmol-2021-egsguidelines"},{"issue":"1","key":"2025_CR2","first-page":"189","volume":"37","author":"M Gotovac","year":"2013","unstructured":"Gotovac\u00a0M, Kastelan\u00a0S, Lukenda\u00a0A (2013) Eye and pregnancy. Coll Antropol 37(1):189\u2013193","journal-title":"Coll Antropol"},{"key":"2025_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/J.MJAFI.2013.03.006","volume":"69","author":"S Chawla","year":"2013","unstructured":"Chawla\u00a0S, Chaudhary\u00a0T, Aggarwal\u00a0S et\u00a0al (2013) Ophthalmic considerations in pregnancy. Med J Armed Forces India 69:278. https:\/\/doi.org\/10.1016\/J.MJAFI.2013.03.006","journal-title":"Med J Armed Forces India"},{"key":"2025_CR4","unstructured":"NCBI Bookshelf Drugs and lactation database (LactMed\u00ae). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/. Zugegriffen: 28. Febr. 2024"},{"key":"2025_CR5","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1080\/14767058.2021.1966410","volume":"35","author":"X Wang","year":"2022","unstructured":"Wang\u00a0X, Zhang\u00a0Y, Yang\u00a0H, Xu\u00a0Y (2022) Maternal-fetal transfer of indocyanine green: a\u00a0systematic review. J\u00a0Matern Fetal Neonatal Med 35:8181\u20138185. https:\/\/doi.org\/10.1080\/14767058.2021.1966410","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/SJ.EYE.6702193","volume":"21","author":"D Vaideanu","year":"2007","unstructured":"Vaideanu\u00a0D, Fraser\u00a0S (2007) Glaucoma management in pregnancy: a\u00a0questionnaire survey. Eye (Lond) 21:341\u2013343. https:\/\/doi.org\/10.1038\/SJ.EYE.6702193","journal-title":"Eye (Lond)"},{"key":"2025_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.OGLA.2019.12.004","volume":"3","author":"A Belkin","year":"2020","unstructured":"Belkin\u00a0A, Chen\u00a0T, DeOliveria\u00a0AR et\u00a0al (2020) A practical guide to the pregnant and breastfeeding patient with glaucoma. Ophthalmol Glaucoma 3:79\u201389. https:\/\/doi.org\/10.1016\/J.OGLA.2019.12.004","journal-title":"Ophthalmol Glaucoma"},{"key":"2025_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/J.OPHTHA.2022.09.009","volume":"130","author":"G Gazzard","year":"2023","unstructured":"Gazzard\u00a0G, Konstantakopoulou\u00a0E, Garway-Heath\u00a0D et\u00a0al (2023) Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology 130:139\u2013151. https:\/\/doi.org\/10.1016\/J.OPHTHA.2022.09.009","journal-title":"Ophthalmology"},{"key":"2025_CR9","first-page":"61","volume":"73","author":"P V\u00fdborn\u00fd","year":"2017","unstructured":"V\u00fdborn\u00fd\u00a0P, Si\u010d\u00e1kov\u00e1\u00a0S, Fl\u00f3rov\u00e1\u00a0Z, Sov\u00e1kov\u00e1\u00a0I (2017) Selective laser trabeculoplasty\u2014implication for medicament glaucoma treatment interruption in pregnant and breastfeeding women. Cesk Slov Oftalmol 73:61\u201363","journal-title":"Cesk Slov Oftalmol"},{"key":"2025_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/11206721231199774","author":"AR Kaufman","year":"2024","unstructured":"Kaufman\u00a0AR, Al-Djasim\u00a0AL, Rivkin\u00a0AC et\u00a0al (2024) Pregnancy outcomes in the medical management of glaucoma: an international multicenter descriptive survey. Eur J Ophthalmol. https:\/\/doi.org\/10.1177\/11206721231199774","journal-title":"Eur J Ophthalmol"},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/JAMAOPHTHALMOL.2022.1092","volume":"140","author":"TS Vajaranant","year":"2022","unstructured":"Vajaranant\u00a0TS (2022) Clinical dilemma-topical prostaglandin use in glaucoma during pregnancy. JAMA Ophthalmol 140:637\u2013638. https:\/\/doi.org\/10.1001\/JAMAOPHTHALMOL.2022.1092","journal-title":"JAMA Ophthalmol"},{"key":"2025_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/JAMAOPHTHALMOL.2022.0628","volume":"140","author":"M Etminan","year":"2022","unstructured":"Etminan\u00a0M, Richter\u00a0L, Sodhi\u00a0M, Mikelberg\u00a0FS (2022) Association of topical prostaglandin analogue use with risk of spontaneous abortion. JAMA Ophthalmol 140:634\u2013636. https:\/\/doi.org\/10.1001\/JAMAOPHTHALMOL.2022.0628","journal-title":"JAMA Ophthalmol"},{"key":"2025_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/25158414211022876","author":"R Kumari","year":"2021","unstructured":"Kumari\u00a0R, Saha\u00a0BC, Onkar\u00a0A et\u00a0al (2021) Management of glaucoma in pregnancy\u2014balancing safety with efficacy. Ther Adv Ophthalmol. https:\/\/doi.org\/10.1177\/25158414211022876","journal-title":"Ther Adv Ophthalmol"},{"key":"2025_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/07853899309147314","volume":"25","author":"AM Heikkil\u00e4","year":"1993","unstructured":"Heikkil\u00e4\u00a0AM (1993) Antibiotics in pregnancy\u2014a prospective cohort study on the policy of antibiotic prescription. Ann Med 25:467\u2013471. https:\/\/doi.org\/10.3109\/07853899309147314","journal-title":"Ann Med"},{"key":"2025_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00347-011-2459-x","volume":"109","author":"T Ness","year":"2012","unstructured":"Ness\u00a0T, Paulus\u00a0W (2012) Ophthalmic agents during pregnancy and breastfeeding. Ophthalmologe 109:221\u2013228. https:\/\/doi.org\/10.1007\/s00347-011-2459-x","journal-title":"Ophthalmologe"},{"key":"2025_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90021-1","author":"H Giamarellou","year":"1989","unstructured":"Giamarellou\u00a0H, Kolokythas\u00a0E, Petrikkos\u00a0G et\u00a0al (1989) Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med. https:\/\/doi.org\/10.1016\/0002-9343(89)90021-1","journal-title":"Am J Med"},{"key":"2025_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS15030804\/S1","author":"A Rusu","year":"2023","unstructured":"Rusu\u00a0A, Munteanu\u00a0AC, Arb\u0103na\u0219i\u00a0EM, Uivarosi\u00a0V (2023) Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a\u00a0step forward in the safety profile? Pharmaceutics. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15030804\/S1","journal-title":"Pharmaceutics"},{"key":"2025_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1517\/14740338.2014.939580","volume":"13","author":"HF Lamont","year":"2014","unstructured":"Lamont\u00a0HF, Blogg\u00a0HJ, Lamont\u00a0RF (2014) Safety of antimicrobial treatment during pregnancy: a\u00a0current review of resistance, immunomodulation and teratogenicity. Expert Opin Drug Saf 13:1569\u20131581. https:\/\/doi.org\/10.1517\/14740338.2014.939580","journal-title":"Expert Opin Drug Saf"},{"key":"2025_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/OGX.0000000000000122","volume":"69","author":"E Yefet","year":"2014","unstructured":"Yefet\u00a0E, Salim\u00a0R, Chazan\u00a0B et\u00a0al (2014) The safety of quinolones in pregnancy. Obstet Gynecol Surv 69:681\u2013694. https:\/\/doi.org\/10.1097\/OGX.0000000000000122","journal-title":"Obstet Gynecol Surv"},{"key":"2025_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1179\/JOC.2005.17.2.123","volume":"17","author":"A Reali","year":"2005","unstructured":"Reali\u00a0A, Ximenes\u00a0A, Cuzzolin\u00a0L, Fanos\u00a0V (2005) Antibiotic therapy in pregnancy and lactation. J\u00a0Chemother 17:123\u2013130. https:\/\/doi.org\/10.1179\/JOC.2005.17.2.123","journal-title":"J Chemother"},{"key":"2025_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N107","author":"NW Andersson","year":"2021","unstructured":"Andersson\u00a0NW, Olsen\u00a0RH, Andersen\u00a0JT (2021) Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study. BMJ. https:\/\/doi.org\/10.1136\/BMJ.N107","journal-title":"BMJ"},{"key":"2025_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0002-9394(88)90597-1","volume":"106","author":"JR Samples","year":"1988","unstructured":"Samples\u00a0JR, Meyer\u00a0SM (1988) Use of ophthalmic medications in pregnant and nursing women. Am J Ophthalmol 106:616\u2013623. https:\/\/doi.org\/10.1016\/0002-9394(88)90597-1","journal-title":"Am J Ophthalmol"},{"key":"2025_CR23","doi-asserted-by":"publisher","DOI":"10.31288\/OFTALMOLZH201713437","author":"GI Drozhzhyna","year":"2017","unstructured":"Drozhzhyna\u00a0GI, Sereda\u00a0EV, Gaydamaka\u00a0TB, Molodaia\u00a0AL (2017) Efficacy of using antibacterial fusidic acid drops in patients with red eye. Oftalmol Zh. https:\/\/doi.org\/10.31288\/OFTALMOLZH201713437","journal-title":"Oftalmol Zh"},{"key":"2025_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/AOS.12737","volume":"93","author":"V Thomseth","year":"2015","unstructured":"Thomseth\u00a0V, Cejvanovic\u00a0V, Jimenez-Solem\u00a0E et\u00a0al (2015) Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a\u00a0Danish nationwide cohort study. Acta Ophthalmol 93:651\u2013653. https:\/\/doi.org\/10.1111\/AOS.12737","journal-title":"Acta Ophthalmol"},{"key":"2025_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/PHAR.1649","volume":"35","author":"PB Bookstaver","year":"2015","unstructured":"Bookstaver\u00a0PB, Bland\u00a0CM, Griffin\u00a0B et\u00a0al (2015) A review of antibiotic use in pregnancy. Pharmacotherapy 35:1052\u20131062. https:\/\/doi.org\/10.1002\/PHAR.1649","journal-title":"Pharmacotherapy"},{"key":"2025_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/BDRA.20013","volume":"70","author":"KM Stone","year":"2004","unstructured":"Stone\u00a0KM, Reiff-Eldridge\u00a0R, White\u00a0AD et\u00a0al (2004) Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984\u20131999. Birth Defects Res Part A Clin Mol Teratol 70:201\u2013207. https:\/\/doi.org\/10.1002\/BDRA.20013","journal-title":"Birth. Defects Res. Part. A. Clin. Mol. Teratol."},{"key":"2025_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/JAMA.2010.1206","volume":"304","author":"B Pasternak","year":"2010","unstructured":"Pasternak\u00a0B, Hviid\u00a0A (2010) Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304:859\u2013866. https:\/\/doi.org\/10.1001\/JAMA.2010.1206","journal-title":"JAMA"},{"key":"2025_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1542\/PEDS.108.3.776","volume":"108","author":"RM Ward","year":"2001","unstructured":"Ward\u00a0RM, Bates\u00a0BA, Benitz\u00a0WE et\u00a0al (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108:776\u2013789. https:\/\/doi.org\/10.1542\/PEDS.108.3.776","journal-title":"Pediatrics"},{"key":"2025_CR29","first-page":"1353","volume":"60","author":"BW Miller","year":"1995","unstructured":"Miller\u00a0BW, Howard\u00a0TK, Goss\u00a0JA et\u00a0al (1995) Renal transplantation one week after conception. Transplantation 60:1353\u20131354","journal-title":"Transplantation"},{"key":"2025_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/00007890-199903150-00021","volume":"67","author":"MD Pescovitz","year":"1999","unstructured":"Pescovitz\u00a0MD (1999) Absence of teratogenicity of oral ganciclovir used during early pregnancy in a\u00a0liver transplant recipient. Transplantation 67:758\u2013759. https:\/\/doi.org\/10.1097\/00007890-199903150-00021","journal-title":"Transplantation"},{"key":"2025_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/J.SURVOPHTHAL.2019.02.007","volume":"64","author":"P Sahay","year":"2019","unstructured":"Sahay\u00a0P, Singhal\u00a0D, Nagpal\u00a0R et\u00a0al (2019) Pharmacologic therapy of mycotic keratitis. Surv Ophthalmol 64:380\u2013400. https:\/\/doi.org\/10.1016\/J.SURVOPHTHAL.2019.02.007","journal-title":"Surv Ophthalmol"},{"key":"2025_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0890-6238(03)00041-8","volume":"17","author":"AE Czeizel","year":"2003","unstructured":"Czeizel\u00a0AE, Kazy\u00a0Z, Vargha\u00a0P (2003) A case-control teratological study of vaginal natamycin treatment during pregnancy. Reprod Toxicol 17:387\u2013391. https:\/\/doi.org\/10.1016\/S0890-6238(03)00041-8","journal-title":"Reprod. Toxicol."},{"key":"2025_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/PHAR.1764","volume":"36","author":"JM Cottreau","year":"2016","unstructured":"Cottreau\u00a0JM, Barr\u00a0VO (2016) A review of antiviral and antifungal use and safety during pregnancy. Pharmacotherapy 36:668\u2013678. https:\/\/doi.org\/10.1002\/PHAR.1764","journal-title":"Pharmacotherapy"},{"key":"2025_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231161387","author":"LSM Sigera","year":"2023","unstructured":"Sigera\u00a0LSM, Denning\u00a0DW (2023) Flucytosine and its clinical usage. Ther Adv Infect Dis. https:\/\/doi.org\/10.1177\/20499361231161387","journal-title":"Ther Adv Infect Dis"},{"key":"2025_CR35","doi-asserted-by":"publisher","DOI":"10.4414\/SMF.2020.08478","author":"T Murer","year":"2020","unstructured":"Murer\u00a0T, Drr\u00a0C, Brgler\u00a0C et\u00a0al (2020) Behandlung allergischer Erkrankungen in der Schwangerschaft. Swiss Med Forum. https:\/\/doi.org\/10.4414\/SMF.2020.08478","journal-title":"Swiss Med Forum"},{"key":"2025_CR36","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/BDR2.1749","volume":"112","author":"C Hansen","year":"2020","unstructured":"Hansen\u00a0C, Desrosiers\u00a0TA, Wisniewski\u00a0K et\u00a0al (2020) Use of antihistamine medications during early pregnancy and selected birth defects: the national birth defects prevention study, 1997\u20132011. Birth Defects Res 112:1234\u20131252. https:\/\/doi.org\/10.1002\/BDR2.1749","journal-title":"Birth Defects Res"},{"key":"2025_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/0976-500X.95503","volume":"3","author":"S Kar","year":"2012","unstructured":"Kar\u00a0S, Krishnan\u00a0A, Preetha\u00a0K, Mohankar\u00a0A (2012) A review of antihistamines used during pregnancy. J\u00a0Pharmacol Pharmacother 3:105. https:\/\/doi.org\/10.4103\/0976-500X.95503","journal-title":"J Pharmacol Pharmacother"},{"key":"2025_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/S40264-016-0479-9","volume":"40","author":"F Etwel","year":"2017","unstructured":"Etwel\u00a0F, Faught\u00a0LH, Rieder\u00a0MJ, Koren\u00a0G (2017) The risk of adverse pregnancy outcome after first trimester exposure to H1 antihistamines: a\u00a0systematic review and meta-analysis. Drug Saf 40:121\u2013132. https:\/\/doi.org\/10.1007\/S40264-016-0479-9","journal-title":"Drug Saf"},{"key":"2025_CR39","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1517\/14740338.2014.970164","volume":"13","author":"SM Gilboa","year":"2014","unstructured":"Gilboa\u00a0SM, Ailes\u00a0EC, Rai\u00a0RP et\u00a0al (2014) Antihistamines and birth defects: a\u00a0systematic review of the literature. Expert Opin Drug Saf 13:1667\u20131698. https:\/\/doi.org\/10.1517\/14740338.2014.970164","journal-title":"Expert Opin Drug Saf"},{"key":"2025_CR40","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/HUMREP\/DET308","volume":"28","author":"WY Almawi","year":"2013","unstructured":"Almawi\u00a0WY, Saldanha\u00a0FL, Mahmood\u00a0NA et\u00a0al (2013) Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. Hum Reprod 28:2628\u20132635. https:\/\/doi.org\/10.1093\/HUMREP\/DET308","journal-title":"Hum Reprod"},{"key":"2025_CR41","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/BJOPHTHALMOL-2014-305252","volume":"98","author":"RL Avery","year":"2014","unstructured":"Avery\u00a0RL, Castellarin\u00a0AA, Steinle\u00a0NC et\u00a0al (2014) Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98:1636\u20131641. https:\/\/doi.org\/10.1136\/BJOPHTHALMOL-2014-305252","journal-title":"Br J Ophthalmol"},{"key":"2025_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2022.1063625","author":"T Sakai","year":"2022","unstructured":"Sakai\u00a0T, Mori\u00a0C, Ohtsu\u00a0F (2022) Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: a\u00a0disproportionality analysis using the food and drug administration adverse event reporting system. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2022.1063625","journal-title":"Front Pharmacol"},{"key":"2025_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41433-023-02811-6","volume":"2023","author":"AY Ong","year":"2023","unstructured":"Ong\u00a0AY, Kiire\u00a0CA, Frise\u00a0C et\u00a0al (2023) Intravitreal anti-vascular endothelial growth factor injections in pregnancy and breastfeeding: a\u00a0case series and systematic review of the literature. Eye (Lond) 2023:1\u201313. https:\/\/doi.org\/10.1038\/s41433-023-02811-6","journal-title":"Eye (Lond)"},{"key":"2025_CR44","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/AJCN\/72.5.1196","volume":"72","author":"P Vuorela","year":"2000","unstructured":"Vuorela\u00a0P, Andersson\u00a0S, Carpen\u00a0O et\u00a0al (2000) Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr 72:1196\u20131201. https:\/\/doi.org\/10.1093\/AJCN\/72.5.1196","journal-title":"Am J Clin Nutr"},{"key":"2025_CR45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/J.OPHTHA.2019.08.022","volume":"127","author":"VR Juncal","year":"2020","unstructured":"Juncal\u00a0VR, Paracha\u00a0Q, Bamakrid\u00a0M et\u00a0al (2020) Ranibizumab and aflibercept levels in breast milk after intravitreal injection. Ophthalmology 127:278\u2013280. https:\/\/doi.org\/10.1016\/J.OPHTHA.2019.08.022","journal-title":"Ophthalmology"},{"key":"2025_CR46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","volume":"5","author":"N Marlow","year":"2021","unstructured":"Marlow\u00a0N, Stahl\u00a0A, Lepore\u00a0D et\u00a0al (2021) 2\u2011year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. Lancet Child Adolesc Health 5:698\u2013707. https:\/\/doi.org\/10.1016\/S2352-4642(21)00195-4","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-024-02025-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-024-02025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:06:04Z","timestamp":1713175564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-024-02025-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s00347-024-02025-5","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"8 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>T.\u00a0Schlote<\/b>: A. Finanzielle Interessen: Augen\u00e4rztliche Praxis Dres Schlote; Augenarzt am Rhein GmbH; Tagesklinik Ambimed Basel AG. \u2013 B. Nichtfinanzielle Interessen: Niedergelassener Augenarzt mit eigener Praxis in Basel, Medizinischer Leiter der Tagesklinik Ambimed Basel AG und Augenarzt am Rhein GmbH | Mitglied der Gesch\u00e4ftsleitung der Augenklinik Heuberger | Mitgliedschaften: DOG, SOG. <b>E.\u00a0Chan<\/b>: A.\u00a0Finanzielle Interessen: E.\u00a0Chan gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt Ambimed | Mitgliedschaft: F\u00fcr diese Fortbildung relevanter Berufsverband: Schweizerische Ophthalmologische Gesellschaft (SOG). <b>U.\u00a0Germann<\/b>: A. Finanzielle Interessen: U. Germann gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Ober\u00e4rztin in der Tagesklinik Ambimed in Basel, Angestellte | Mitgliedschaften: Schweizerische ophthalmologische Gesellschaft, VSAO (Verband der schweizerischen Assistenz- und Ober\u00e4rzte), medizinische Gesellschaft Basel.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}